- Home
- HUCK vs ANTX Comparison
HUCK vs ANTX Comparison
Compare HUCK & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.15
HOLD
Current Price
$5.23
Company Overview
Basic Information| Metric | HUCK | ANTX |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.5M | 172.9M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HUCK | ANTX |
|---|---|---|
| Price | $3.15 | $5.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.17 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 666.0K | 223.7K |
| Earning Date | 09-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.92 | ★ 32.56 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $318,857,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.33 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.16 | $1.00 |
| 52 Week High | $3.45 | $7.19 |
Technical Indicators
Market Signals| Indicator | HUCK | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 16.33 | 48.14 |
| Support Level | N/A | $4.61 |
| Resistance Level | $3.45 | $7.05 |
| Average True Range (ATR) | 0.15 | 0.38 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 10.23 | 48.74 |
Price Performance
Historical Comparison HUCK
ANTX
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.